Epigenetic tête-à-tête: The bilateral relationship between chromatin modifications and DNA methylation

Biochemistry and Cell Biology

Volumn 84, Issue 4, 2006, Pages 463-476

  D'Alessio, Ana C ^a   Szyf, Moshe ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; Chromatin structure; DNA methylation

Indexed keywords

CYTOLOGY; DNA; GENES; GENETIC ENGINEERING; PROTEINS;

CHROMATIN STRUCTURE; DNA METHYLATION; EPIGENETIC REPROGRAMMING; GENE EXPRESSION;

CELLS;

ANTISENSE OLIGONUCLEOTIDE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; HISTONE ACETYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2; TRICHOSTATIN A;

ACETYLATION; CANCER CELL; CANCER GENETICS; CELL TRANSFORMATION; CHROMATIN STRUCTURE; CONFERENCE PAPER; DEMETHYLATION; DNA BINDING; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; DRUG MECHANISM; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC ANALYSIS; NONHUMAN;

ACETYLATION; ANIMALS; CHROMATIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONES; HUMANS; MODELS, GENETIC; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33750688857     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O06-090     Document Type: Conference Paper

References (135)

1. Angrisano, T., Lembo, F., Pero, R., Natale, F., Fusco, A., Avvedimento, V.E., Bruni, C.B., and Chiariotti, L. 2006. TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters. Nucleic Acids Res. 34: 364-372. doi:10.1093/nar/gkj400. PMID:16410616.
2. Araujo, F.D., Knox, J.D., Szyf, M., Price, G.B., and Zannis-Hadjopoulos, M. 1998. Concurrent replication and methylation at mammalian origins of replication. Mol. Cell. Biol. 18: 3475-3482. PMID:9584187.
3. Ayton, P.M., and Cleary, M.L. 2001. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene, 20: 5695-5707. doi:10.1038/sj.onc.1204639. PMID:11607819.
4. Bachman, K.E., Park, B.H., Rhee, I., Rajagopalan, H., Herman, J.G., Baylin, S.B., Kinzler, K.W., and Vogelstein, B. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell, 3: 89-95. doi:10.1016/S1535-6108(02)00234-9. PMID:12559178.
5. Baylin, S.B., Esteller, M., Rountree, M.R., Bachman, K.E., Schuebel, K., and Herman, J.G. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10: 687-692. doi:10.1093/hmg/10.7.687. PMID:11257100.
6. Bhattacharya, S.K., Ramchandani, S., Cervoni, N., and Szyf, M. 1999. A mammalian protein with specific demethylase activity for mCpG DNA. Nature (London), 397: 579-583. PMID:10050851.
7. Bracken, A.P., Pasini, D., Capra, M., Prosperini, E., Colli, E., and Helin, K. 2003. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22: 5323-5335. PMID:14532106.
8. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Vire, E., De Smet, C., et al. 2005. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24: 336-346. doi:10.1038/sj.emboj. 7600509. PMID:15616584.
9. Bruniquel, D., and Schwartz, R.H. 2003. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4: 235-240. doi:10.1038/ni887. PMID:12548284.
10. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G., and Baylin, S.B. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21: 103-107. doi:10.1038/5047. PMID:9916800.
11. Campbell, P.M., Bovenzi, V., and Szyf, M. 2004. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis, 25: 499-507. PMID:14688029.
12. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R.S., and Zhang, Y. 2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (Washington, D.C.), 298: 1039-1043. doi:10.1126/science.1076997. PMID:12351676.
13. Cervoni, N., and Szyf, M. 2001. Demethylase activity is directed by histone acetylation. J. Biol. Chem. 276: 40 778-40 787. doi:10.1074/jbc. M103921200. PMID:11524416.
14. Cervoni, N., Bhattacharya, S., and Szyf, M. 1999. DNA demethylase is a processive enzyme. J. Biol. Chem. 274: 8363-8366. doi:10.1074/jbc.274.13.8363. PMID:10085064.
15. Cervoni, N., Detich, N., Seo, S.B., Chakravarti, D., and Szyf, M. 2002. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J. Biol. Chem. 277: 25 026-25 031. doi:10.1074/jbc.M202256200. PMID:11978794.
16. Chalitchagorn, K., Shuangshoti, S., Hourpai, N., Kongruttanachok, N., Tangkijvanich, P., Thong-ngam, D., et al. 2004. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene, 23: 8841-8846. doi:10.1038/sj.onc.1208137. PMID:15480421.
17. Chen, T., Ueda, Y., Dodge, J.E., Wang, Z., and Li, E. 2003. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23: 5594-5605. doi:10.1128/MCB.23.16. 5594-5605. 2003. PMID:12897133.
18. Comb, M., and Goodman, H.M. 1990. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 18: 3975-3982. PMID:1695733.
19. Costa, E., Grayson, D.R., Mitchell, C.P., Tremolizzo, L., Veldic, M., and Guidotti, A. 2003. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit. Rev. Neurobiol. 15: 121-142. doi:10.1615/CritRevNeurobiol. v15.i2.20. PMID:14977367.
20. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S., and van Kuilenburg, A.B. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370: 737-749. doi:10.1042/BJ20021321. PMID:12429021.
21. Detich, N., Theberge, J., and Szyf, M. 2002. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 277: 35 791-35 794. doi:10.1074/jbc.C200408200. PMID:12177048.
22. Detich, N., Bovenzi, V., and Szyf, M. 2003. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278: 27 586-27 592. doi:10.1074/jbc.M303740200. PMID:12748177.
23. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science (Washington, D.C.), 295: 1079-1082. doi:10.1126/science.1065173. PMID:11834837.
24. Eden, S., Hashimshony, T., Keshet, I., Cedar, H., and Thorne, A.W. 1998. DNA methylation models histone acetylation. Nature (London), 394: 842. doi:10.1038/29680. PMID:9732866.
25. Eden, A., Gaudet, F., Waghmare, A., and Jaenisch, R. 2003. Chromosomal instability and tumors promoted by DNA hypomethylation. Science (Washington, D.C.), 300: 455. doi:10.1126/science.1083557. PMID:12702868.
26. Ego, T., Tanaka, Y., and Shimotohno, K. 2005. Interaction of HTLV-1 Tax and methyl-CpG-binding domain 2 positively regulates the gene expression from the hypermethylated LTR. Oncogene, 24: 1914-1923. doi:10.1038/sj.onc.1208394. PMID:15674330.
27. Ehrlich, M. 2003. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin. Immunol. 109: 17-28. doi:10.1016/S1521- 6616(03)00201-8. PMID:14585272.
28. Enver, T., Zhang, J.W., Papayannopoulou, T., and Stamatoyannopoulos, G. 1988. DNA methylation: a secondary event in globin gene switching? Genes Dev. 2: 698-706. PMID:2458298.
29. Feinberg, A.P., and Vogelstein, B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (London), 301: 89-92. doi:10.1038/301089a0. PMID:6185846.
30. Feinberg, A.P., Gehrke, C.W., Kuo, K.C., and Ehrlich, M. 1988. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48: 1159-1161. PMID:3342396.
31. Feng, Q., and Zhang, Y. 2001. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15: 827-832. PMID:11297506.
32. Ferres-Marco, D., Gutierrez-Garcia, I., Vallejo, D.M., Bolivar, J., Gutierrez-Avino, F.J., and Dominguez, M. 2006. Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature, 439: 430-436. doi:10.1038/nature04376. PMID:16437107.
33. Filetici, P., P, O., and Ballario, P. 2001. The bromodomain: a chromatin browser? Front. Biosci. 6: D866-D876. PMID:11487466.
34. Frank, D., Lichtenstein, M., Paroush, Z., Bergman, Y., Shani, M., Razin, A., and Cedar, H. 1990. Demethylation of genes in animal cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 326: 241-251. PMID:1968661.
35. Frolov, M.V., and Dyson, N.J. 2004. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117: 2173-2181. doi:10.1242/jcs.01227. PMID:15126619.
36. Fujita, H., Fujii, R., Aratani, S., Amano, T., Fukamizu, A., and Nakajima, T. 2003. Antithetic effects of MBD2a on gene regulation. Mol. Cell. Biol. 23: 2645-2657. doi:10.1128/MCB.23.8.2645-2657.2003. PMID:12665568.
37. Fuks, F., Burgers, W.A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24: 88-91. PMID:10615135.
38. Fuks, F., Hurd, P.J., Deplus, R., and Kouzarides, T. 2003. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31: 2305-2312. doi:10.1093/nar/gkg332. PMID:12711675.
39. Gaudet, F., Hodgson, J.G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J.W., Leonhardt, H., and Jaenisch, R. 2003. Induction of tumors in mice by genomic hypomethylation. Science (Washington, D.C.), 300: 489-492. doi:10.1126/science.1083558. PMID:12702876.
40. Gibbons, R.J. 2005. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14: R85-R92. doi:10.1093/hmg/ddi106. PMID:15809277.
41. Gius, D., Cui, H., Bradbury, C.M., Cook, J., Smart, D.K., Zhao, S., et al. 2004. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell, 6: 361-371. doi:10.1016/j.ccr.2004.08.029. PMID:15488759.
42. Goffin, J., and Eisenhauer, E. 2002. DNA methyltransferase inhibitors-state of the art. Ann. Oncol. 13: 1699-1716. doi:10.1093/annonc/ mdf314. PMID:12419742.
43. Guo, Y., Pakneshan, P., Gladu, J., Slack, A., Szyf, M., and Rabbani, S.A. 2002. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. J. Biol. Chem. 277: 41 571-41 579. doi:10.1074/jbc.M201864200. PMID:12198113.
44. Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F.P., Li, M., Yagyu, R., and Nakamura, Y. 2004. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol. 6: 731-740. doi:10.1038/ncb1151. PMID:15235609.
45. Hattori, M., Sakamoto, H., and Yamamoto, T. 2001a. DNA demethylase expression correlates with lung resistance protein expression in common epithelial ovarian cancers. J. Int. Med. Res. 29: 204-213. PMID:11471858.
46. Hattori, M., Sakamoto, H., Satoh, K., and Yamamoto, T. 2001b. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett. 169: 155-164. doi:10.1016/S0304-3835(01)00499-2. PMID:11431104.
47. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V.A., and Bird, A. 2001. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15: 710-723. doi:10.1101/gad.194101. PMID:11274056.
48. Henikoff, S. 2000. Heterochromatin function in complex genomes. Biochim. Biophys. Acta, 1470: O1-O8. PMID:10656988.
49. Henikoff, S., McKittrick, E., and Ahmad, K. 2004. Epigenetics, histone H3 variants, and the inheritance of chromatin states. Cold Spring Harb. Symp. Quant. Biol. 69: 235-243. doi:10.1101/sqb.2004.69.235. PMID:16117654.
50. Hess, J.L. 2004. Mechanisms of transformation by MLL. Crit. Rev. Eukaryot. Gene Expr. 14: 235-254. doi:10.1615/CritRevEukaryotGeneExpr.v14.i4.10. PMID:15663355.
51. Iyer, N.G., Ozdag, H., and Caldas, C. 2004. p300/CBP and cancer. Oncogene, 23: 4225-4231. doi:10.1038/sj.onc.1207118. PMID:15156177.
52. Jackson, J.P., Lindroth, A.M., Cao, X., and Jacobsen, S.E. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature (London), 416: 556-560. doi:10.1038/nature731. PMID:11898023.
53. Jair, K.W., Bachman, K.E., Suzuki, H., Ting, A.H., Rhee, I., Yen, R.W., Baylin, S.B., and Schuebel, K.E. 2006. De novo CpG island methylation in human cancer cells. Cancer Res. 66: 682-692. doi:10.1158/0008-5472.CAN-05-1980. PMID:16423997.
54. Johnson, L., Cao, X., and Jacobsen, S. 2002. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol. 12: 1360-1367. doi:10.1016/S0960-9822(02)00976-4. PMID:12194816.
55. Jost, J.P., Oakeley, E.J., Zhu, B., Benjamin, D., Thiry, S., Siegmann, M., and Jost, Y.C. 2001. 5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation. Nucleic Acids Res. 29: 4452-4461. doi:10.1093/nar/29.21.4452. PMID:11691933.
56. Kanai, Y., Ushijima, S., Nakanishi, Y., and Hirohashi, S. 1999. Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers. Biochem. Biophys. Res. Commun. 264: 962-966. doi:10.1006/bbrc.1999. 1613. PMID:10544038.
57. Kersh, E.N., Fitzpatrick, D.R., Murali-Krishna, K., Shires, J., Speck, S.H., Boss, J.M., and Ahmed, R. 2006. Rapid demethylation of the IFN-{gamma} gene occurs in memory but not naive CD8 T Cells. J. Immunol. 176: 4083-4093. PMID:16547244.
58. Kim, G.D., Ni, J., Kelesoglu, N., Roberts, R.J., and Pradhan, S. 2002. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21: 4183-4195. PMID:12145218.
59. Kirillov, A., Kistler, B., Mostoslavsky, R., Cedar, H., Wirth, T., and Bergman, Y. 1996. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat. Genet. 13: 435-441. doi:10.1038/ng0895-435. PMID:8696338.
60. Kleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A., et al. 2003. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 100: 11606-11611. doi:10.1073/pnas.1933744100. PMID:14500907.
61. Kuo, M.H., and Allis, C.D. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays, 20: 615-626. doi:10.1002/(SICI)1521- 1878(199808)20:8<615::AIDBIES4>3.0.CO;2-H. PMID:9780836.
62. Lachner, M., and Jenuwein, T. 2002. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14: 286-298. doi:10.1016/S0955-0674(02) 00335-6. PMID:12067650.
63. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., and Jenuwein, T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (London). 410: 116-120. doi:10.1038/35065132. PMID:11242053.
64. Le Guezennec, X., Vermeulen, M., Brinkman, A.B., Hoeijmakers, W.A., Cohen, A., Lasonder, E., and Stunnenberg, H.G. 2006. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol. Cell. Biol. 26: 843-851. doi:10.1128/MCB.26.3.843-851.2006. PMID:16428440.
65. Lee, M.G., Wynder, C., Cooch, N., and Shiekhattar, R. 2005. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature (London), 437: 432-435. PMID:16079794.
66. Lehnertz, B., Ueda, Y., Derijck, A.A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., et al. 2003. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13: 1192-1200. doi:10.1016/S0960-9822(03)00432-9. PMID:12867029.
67. Lembo, F., Pero, R., Angrisano, T., Vitiello, C., Iuliano, R., Bruni, C.B., and Chiariotti, L. 2003. MBDin, a novel MBD2-interacting protein, relieves MBD2 repression potential and reactivates transcription from methylated promoters. Mol. Cell. Biol. 23: 1656-1665. doi:10.1128/MCB.23.5.1656-1665.2003. PMID:12588985.
68. Liang, G., Chan, M.F., Tomigahara, Y., Tsai, Y.C., Gonzales, F.A., Li, E., Laird, P.W., and Jones, P.A. 2002. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22: 480-491. doi:10.1128/MCB.22.2.480-491.2002. PMID:11756544.
69. Lichtenstein, M., Keini, G., Cedar, H., and Bergman, Y. 1994. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence. Cell, 76: 913-923. doi:10.1016/0092-8674(94)90365-4. PMID:8124725.
70. Lock, L.F., Takagi, N., and Martin, G.R. 1987. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell, 48: 39-46. doi:10.1016/0092-8674(87)90353-9. PMID:3791414.
71. Lu, L.J., Randerath, E., and Randerath, K. 1983. DNA hypomethylation in Morris hepatomas. Cancer Lett. 19: 231-239. doi:10.1016/0304-3835(83)90159-3. PMID:6192902.
72. Lucarelli, M., Fuso, A., Strom, R., and Scarpa, S. 2001. The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J. Biol. Chem. 276: 7500-7506. doi:10.1074/jbc.M008234200. PMID:11096088.
73. Lyko, F., Ramsahoye, B.H., and Jaenisch, R. 2000. DNA methylation in Drosophila melanogaster. Nature (London), 408: 538-540. PMID:11117732.
74. Marhold, J., Zbylut, M., Lankenau, D.H., Li, M., Gerlich, D., Ballestar, E., Mechler, B.M., and Lyko, F. 2002. Stage-specific chromosomal association of Drosophila dMBD2/3 during genome activation. Chromosoma, 111: 13-21. doi:10.1007/s00412-002-0188-2. PMID:12068919.
75. Meaney, M.J., and Szyf, M. 2005. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin. Neurosci. 7: 103-123. PMID:16262207.
76. Metzger, E., Wissmann, M., Yin, N., Muller, J.M., Schneider, R., Peters, A.H., et al. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature (London), 437: 436-439. PMID:16079795.
77. Milne, T.A., Hughes, C.M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., et al. 2005. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 102: 749-754. doi:10.1073/pnas.0408836102. PMID:15640349.
78. Muchardt, C., and Yaniv, M. 1999. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J. Mol. Biol. 293: 187-198. doi:10.1006/jmbi. 1999.2999. PMID:10529347.
79. Nan, X., Cross, S., and Bird, A. 1998a. Gene silencing by methyl-CpG-binding proteins. Novartis Found. Symp. 214: 6-16. PMID:9601009.
80. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. 1998b. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (London), 393: 386-389. PMID:9620804.
81. Ng, H.H., Zhang, Y., Hendrich, B., Johnson, C.A., Turner, B.M., Erdjument-Bromage, H., et al. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23: 58-61. PMID:10471499.
82. Okano, M., Bell, D.W., Haber, D.A., and Li, E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99: 247-257. doi:10.1016/S0092-8674(00)81656-6. PMID:10555141.
83. Oswald, J., Engemann, S., Lane, N., Mayer, W., Olek, A., Fundele, R., et al. 2000. Active demethylation of the paternal genome in the mouse zygote. Curr. Biol. 10: 475-478. doi:10.1016/S0960-9822(00)00448-6. PMID:10801417.
84. Pakneshan, P., Xing, R.H., and Rabbani, S.A. 2003. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo. FASEB J. 17: 1081-1088. doi:10.1096/fj.02-0973com. PMID:12773490.
85. Pakneshan, P., Szyf, M., Farias-Eisner, R., and Rabbani, S.A. 2004. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem. 279: 31 735-31 744. doi:10.1074/jbc.M401669200. PMID:15150277.
86. Pakneshan, P., Szyf, M., and Rabbani, S.A. 2005. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells. Carcinogenesis, 26: 557-564. PMID:15618232.
87. Paroush, Z., Keshet, I., Yisraeli, J., and Cedar, H. 1990. Dynamics of demethylation and activation of the alpha-actin gene in myoblasts. Cell, 63: 1229-1237. doi:10.1016/0092-8674(90)90418-E. PMID:2261641.
88. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell, 107: 323-337. doi:10.1016/S0092-8674(01)00542-6. PMID:11701123.
89. Prendergast, G.C., Lawe, D., and Ziff, E.B. 1991. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell, 65: 395-407. doi:10.1016/0092-8674(91)90457-A. PMID:1840505.
90. Pruss, D., Hayes, J.J., and Wolffe, A.P. 1995. Nucleosomal anatomy-where are the histones? Bioessays, 17: 161-170. doi:10.1002/bies.950170211. PMID:7748166.
91. Pusarla, R.H., and Bhargava, P. 2005. Histones in functional diversification. Core histone variants. FEBS J. 272: 5149-5168. doi:10.1111/j.1742-4658.2005.04930.x. PMID:16218948.
92. Ramchandani, S., Bhattacharya, S.K., Cervoni, N., and Szyf, M. 1999. DNA methylation is a reversible biological signal. Proc. Natl. Acad. Sci. U.S.A. 96: 6107-6112. doi:10.1073/pnas.96.11.6107. PMID:10339549.
93. Razin, A., and Cedar, H. 1977. Distribution of 5-methylcytosine in chromatin. Proc. Natl. Acad. Sci. U.S.A. 74: 2725-2728. doi:10.1073/pnas.74.7. 2725. PMID:268622.
94. Razin, A., and Riggs, A.D. 1980. DNA methylation and gene function. Science (Washington, D.C.), 210: 604-610. PMID:6254144.
95. Razin, A., and Szyf, M. 1984. DNA methylation patterns. Formation and function. Biochim. Biophys. Acta, 782: 331-342. PMID:6383476.
96. Razin, A., Webb, C., Szyf, M., Yisraeli, J., Rosenthal, A., Naveh-Many, T., Sciaky-Gallili, N., and Cedar, H. 1984. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 81: 2275-2279. doi:10.1073/pnas.81.8.2275. PMID:6585800.
97. Ropero, S., Fraga, M.F., Ballestar, E., Hamelin, R., Yamamoto, H., Boix-Chornet, M., et al. 2006. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat. Genet. 38: 566-569. doi:10.1038/ng1773. PMID:16642021.
98. Rosty, C., Ueki, T., Argani, P., Jansen, M., Yeo, C.J., Cameron, J.L., Hruban, R.H., and Goggins, M. 2002. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160: 45-50. PMID:11786397.
99. Rountree, M.R., Bachman, K.E., and Baylin, S.B. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25: 269-277. doi:10.1038/77023. PMID:10888872.
100. Sansom, O.J., Berger, J., Bishop, S.M., Hendrich, B., Bird, A., and Clarke, A.R. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat. Genet. 34: 145-147. doi:10.1038/ng1155. PMID:12730693.
101. Santos-Rosa, H., and Caldas, C. 2005. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer, 41: 2381-2402. PMID:16226460.
102. Santos-Rosa, H., Schneider, R., Bannister, A.J., Sherriff, J., Bernstein, B.E., Emre, N.C., et al. 2002. Active genes are tri-methylated at K4 of histone H3. Nature (London), 419: 407-411. doi:10.1038/nature01080. PMID:12353038.
103. Sarma, K., and Reinberg, D. 2005. Histone variants meet their match. Nat. Rev. Mol. Cell Biol. 6: 139-149. doi:10.1038/nrm1567. PMID:15688000.
104. Sato, N., Fukushima, N., Matsubayashi, H., and Goggins, M. 2004. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene, 23: 1531-1538. doi:10.1038/sj.onc.1207269. PMID:14716296.
105. Selker, E.U. 1998. Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc. Natl. Acad. Sci. U.S.A. 95: 9430-9435. doi:10.1073/pnas.95.16.9430. PMID:9689097.
106. Sengupta, S., Shimamoto, A., Koshiji, M., Pedeux, R., Rusin, M., Spillare, E.A., et al. 2005. Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene, 24: 1738-1748. doi:10.1038/sj.onc.1208380. PMID:15674334.
107. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J.R., Cole, P.A., Casero, R.A., and Shi, Y. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119: 941-953. doi:10.1016/j.cell.2004.12.012. PMID:15620353.
108. Simonini, M.V., Camargo, L.M., Dong, E., Maloku, E., Veldic, M., Costa, E., and Guidotti, A. 2006. The benzamide M.S.-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 103: 1587-1592. doi:10.1073/pnas.0510341103. PMID:16432198.
109. Slack, A., Ivanov, M.A., Bigey, P., Ramchandani, S., Bhattacharya, S., tenOver, B., Lamrihi, B., Scherman, D., and Szyf, M. 2001. MBD2/demethylase is required for tumorigenesis. submitted.
110. Strahl, B.D., and Allis, C.D. 2000. The language of covalent histone modifications. Nature (London), 403: 41-45. PMID:10638745.
111. Strunnikova, M., Schagdarsurengin, U., Kehlen, A., Garbe, J.C., Stampfer, M.R., and Dammann, R. 2005. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol. Cell. Biol. 25: 3923-3933. doi:10.1128/MCB.25.10.3923-3933.2005. PMID:15870267.
112. Szyf, M. 2001. Towards a pharmacology of DNA methylation. Trends Pharmacol. Sci. 22: 350-354. doi:10.1016/S0165-6147(00)01713-2. PMID:11431029.
113. Szyf, M. 2005. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc.), 70: 533-549. PMID:15948707.
114. Szyf, M., and Detich, N. 2001. Regulation of the DNA methylation machinery and its role in cellular transformation. Prog. Nucleic Acid Res. Mol. Biol. 69: 47-79. PMID:11550798.
115. Szyf, M., Eliasson, L., Mann, V., Klein, G., and Razin, A. 1985. Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle. Proc. Natl. Acad. Sci. U.S.A. 82: 8090-8094. doi:10.1073/pnas.82. 23.8090. PMID:2999791.
116. Szyf, M., Pakneshan, P., and Rabbani, S.A. 2004a. DNA demethylation and cancer: therapeutic implications. Cancer Lett. 211: 133-143. doi:10.1016/j.canlet.2004.04.009. PMID:15219937.
117. Szyf, M., Pakneshan, P., and Rabbani, S.A. 2004b. DNA methylation and breast cancer. Biochem. Pharmacol. 68: 1187-1197. doi:10.1016/j.bcp.2004.04.030. PMID:15313416.
118. Tamaru, H., Zhang, X., McMillen, D., Singh, P.B., Nakayama, J., Grewal, S.I., et al. 2003. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34: 75-79. doi:10.1038/ng1143. PMID:12679815.
119. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M.E., Borchers, C.H., Tempst, P., and Zhang, Y. 2006. Histone demethylation by a family of JmjC domain-containing proteins. Nature (London), 439: 811-816. doi:10.1038/ nature04433. PMID:16362057.
120. Urieli-Shoval, S., Gruenbaum, Y., Sedat, J., and Razin, A. 1982. The absence of detectable methylated bases in Drosophila melanogaster DNA. FEBS Lett. 146: 148-152. doi:10.1016/0014-5793(82)80723-0. PMID:6814955.
121. Varambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Kumar-Sinha, C., Sanda, M.G., et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (London), 419: 624-629. doi:10.1038/nature01075. PMID:12374981.
122. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature (London), 439: 871-874. PMID:16357870.
123. Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., et al. 2004. Epigenetic programming by maternal behavior. Nat. Neurosci. 7: 847-854. doi:10.1038/nn1276. PMID:15220929.
124. Wilks, A.F., Cozens, P.J., Mattaj, I.W., and Jost, J.P. 1982. Estrogen induces a demethylation at the 5′ end region of the chicken vitellogenin gene. Proc. Natl. Acad. Sci. U.S.A. 79: 4252-4255. doi:10.1073/pnas.79.14.4252. PMID:6956855.
125. Wolffe, A.P., and Hayes, J.J. 1999. Chromatin disruption and modification. Nucleic Acids Res. 27: 711-720. doi:10.1093/nar/27.3.711. PMID:9889264.
126. Wu, J.C., and Santi, D.V. 1985. On the mechanism and inhibition of DNA cytosine methyltransferases. Prog. Clin. Biol. Res. 198: 119-129. PMID:4070306.
127. Yan, Q., Huang, J., Fan, T., Zhu, H., and Muegge, K. 2003. Lsh, a modulator of CpG methylation, is crucial for normal histone methylation. EMBO J. 22: 5154-5162. PMID:14517253.
128. Zhang, Y., and Reinberg, D. 2001. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15: 2343-2360. doi:10.1101/gad.927301. PMID:11562345.
129. Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13: 1924-1935. PMID:10444591.
130. Zhang, Q., Yao, H., Vo, N., and Goodman, R.H. 2000. Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP. Proc. Natl. Acad. Sci. U.S.A. 97: 14323-14328. doi:10.1073/pnas.011283598. PMID:11114158.
131. Zhang, H., Roberts, D.N., and Cairns, B.R. 2005. Genome-wide dynamics of Htz1, a histone H2A variant that poises repressed/basal promoters for activation through histone loss. Cell, 123: 219-231. doi:10.1016/j.cell.2005.08.036. PMID:16239141.
132. Zhu, B., Zheng, Y., Angliker, H., Schwarz, S., Thiry, S., Siegmann, M., and Jost, J.P. 2000. 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res. 28: 4157-4165. doi:10.1093/nar/28.21.4157. PMID:11058112.
133. Zhu, B., Benjamin, D., Zheng, Y., Angliker, H., Thiry, S., Siegmann, M., and Jost, J.P. 2001. Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene. Proc. Natl. Acad. Sci. U.S.A. 98: 5031-5036. doi:10.1073/pnas. 091097298. PMID:11296268.
134. Zhu, H., Geiman, T.M., Xi, S., Jiang, Q., Schmidtmann, A., Chen, T., Li, E., and Muegge, K. 2006. Lsh is involved in de novo methylation of DNA. EMBO J. 25: 335-345. doi:10.1038/sj.emboj.7600925. PMID:16395332.
135. Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.P., and Gottlicher, M. 2004. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell, 5: 455-463. doi:10.1016/S1535-6108(04) 00114-X. PMID:15144953.